NCI 7M25 Sees 23% Year-Over-Year Increase in Gross Premium Income
NCI Gross Premium Income: NCI reported a gross premium income of RMB137.8 billion for the period from January 1 to July 31, 2025, reflecting a 23% year-over-year increase.
Stock Performance: The stock price of NCI (01336.HK) decreased by 0.400 (-0.765%) as of the latest update.
Short Selling Activity: There was significant short selling activity with a total of $130.30 million and a ratio of 16.342%.
Investor Interest: According to G Sachs, overseas investors are engaging in China's economic recovery through investments in insurance stocks.
Trade with 70% Backtested Accuracy
Analyst Views on 01336
About the author
<Study> HSBC Research Evaluates Ratings and Target Prices for Chinese Insurers (Table)
H Shares Performance: China Life and Ping An saw increases in share prices, while CPIC and NCI experienced slight declines; short selling ratios indicate varying investor sentiment across these companies.
A Shares Performance: China Life and Ping An of China had mixed results, with Ping An's rating upgraded from Hold to Buy, while NCI maintained a Hold rating despite a price increase.
Investment Ratings: Analysts have assigned ratings of Hold, Buy, and Underweight to various insurance companies, reflecting differing outlooks on their future performance.
Market Insights: CICC anticipates a new era in China's commercial health insurance sector, emphasizing four key areas for development.
HSBC Research: Continued Optimism for Chinese Life Insurers; PING AN Named Top Choice in the Sector
Strong 2025 Results: Chinese insurers reported robust results for 2025, driven by higher investment returns from a stock market rebound, according to HSBC Global Research.
Shift in Investment Strategy: Insurers are changing their product mix towards participating products with lower guaranteed returns, focusing on creating new business value.
PING AN Upgrade: HSBC upgraded PING AN OF CHINA's A-shares from Hold to Buy, favoring it over CHINA LIFE, and identified it as a top pick due to its strong agency team and enhanced bargaining power with banks.
Cautious Outlook on NCI and CHINA LIFE: HSBC expressed caution regarding NCI and CHINA LIFE, highlighting their higher sensitivity to capital market fluctuations compared to PING AN.
CICC Ratings and Target Prices for Chinese Insurers (Table)
Stock Performance: Several insurance companies, including PING AN and CHINA LIFE, showed positive stock performance with increases of 2.423% and 5.345%, respectively.
Short Selling Data: The short selling ratios for these companies varied, with CPIC having the highest ratio at 28.360%, while NCI had the lowest at 5.968%.
Analyst Ratings: All listed companies received an "Outperform" rating, indicating positive expectations from analysts.
Market Outlook: Citi has raised target prices for life insurers, favoring leaders like CHINA LIFE and PING AN, and anticipates a prosperous year for the Chinese life insurance sector.
Citi's Ratings and Target Prices for Chinese Insurers (Table)
Stock Performance: Various Chinese insurance companies showed mixed stock performance, with China Life and Ping An experiencing notable gains, while China Re remained stable.
Short Selling Data: Short selling activity varied across companies, with Ping An having the highest short selling amount at $345.76M and a ratio of 18.733%.
Investment Ratings: Analysts have given "Buy" ratings to China Life, CPIC, PICC Group, PICC P&C, and Ping An, while China Re, China Taiping, and NCI received "Neutral" ratings.
Target Prices: Target prices for the companies range from 1.37 to 79 HKD, indicating potential growth opportunities for investors in the insurance sector.
Citi Favors CHINA LIFE and PING AN for Chinese Insurers, and PICC P&C for Property Insurance
Citi's Report on Chinese Insurers: Citi predicts that life insurers in China will benefit from a wealth reallocation as retail investors seek higher yields from maturing bank deposits, while profit margins are expected to remain stable despite changes in product mix.
Investment Recommendations: Citi favors leading insurers like CHINA LIFE and PING AN, anticipating a significant growth divergence between these industry leaders and smaller insurers due to ongoing regulatory changes.
Property Insurance Sector Outlook: The report highlights that PICC P&C is likely to outperform in the property insurance sector, benefiting from its leading position.
Stock Ratings and Target Prices: Citi provides specific stock ratings and target prices for various insurers, recommending buys for CHINA LIFE, CPIC, and PICC P&C, while maintaining neutral ratings for others like CHINA RE and CHINA TAIPING.
JPM Favoring Asian Insurance Market (Excluding Japan/Australia) in Year of the Horse; Key Selections Include PING AN and CHINA LIFE
Price Changes in Asian Insurers: Asian insurers have seen significant price fluctuations, with Hong Kong/China insurers increasing by an average of 8%, while South Korean insurers have decreased by 2%. JPMorgan suggests that emerging markets in Asia, excluding Japan and Australia, offer better risk-reward opportunities due to stronger fundamentals.
Preference for Life Insurers: JPMorgan favors life insurers over non-life and reinsurers, citing less favorable underwriting cycles and pricing trends for the latter. Key recommendations include PING AN and CHINA LIFE among others.
Investment Ratings and Target Prices: JPMorgan has provided investment ratings and target prices for various insurers, with AIA, CHINA LIFE, and PING AN rated as "Overweight" and target prices set at 107, 40, and 100 HKD respectively.
Short Selling Data: The report includes short selling data for the mentioned stocks, indicating significant short selling activity, particularly for PING AN and CHINA LIFE, with ratios of 20.220% and 17.234% respectively.
<Study> HSBC Research Evaluates Ratings and Target Prices for Chinese Insurers (Table)
H Shares Performance: China Life and Ping An saw increases in share prices, while CPIC and NCI experienced slight declines; short selling ratios indicate varying investor sentiment across these companies.
A Shares Performance: China Life and Ping An of China had mixed results, with Ping An's rating upgraded from Hold to Buy, while NCI maintained a Hold rating despite a price increase.
Investment Ratings: Analysts have assigned ratings of Hold, Buy, and Underweight to various insurance companies, reflecting differing outlooks on their future performance.
Market Insights: CICC anticipates a new era in China's commercial health insurance sector, emphasizing four key areas for development.
HSBC Research: Continued Optimism for Chinese Life Insurers; PING AN Named Top Choice in the Sector
Strong 2025 Results: Chinese insurers reported robust results for 2025, driven by higher investment returns from a stock market rebound, according to HSBC Global Research.
Shift in Investment Strategy: Insurers are changing their product mix towards participating products with lower guaranteed returns, focusing on creating new business value.
PING AN Upgrade: HSBC upgraded PING AN OF CHINA's A-shares from Hold to Buy, favoring it over CHINA LIFE, and identified it as a top pick due to its strong agency team and enhanced bargaining power with banks.
Cautious Outlook on NCI and CHINA LIFE: HSBC expressed caution regarding NCI and CHINA LIFE, highlighting their higher sensitivity to capital market fluctuations compared to PING AN.
CICC Ratings and Target Prices for Chinese Insurers (Table)
Stock Performance: Several insurance companies, including PING AN and CHINA LIFE, showed positive stock performance with increases of 2.423% and 5.345%, respectively.
Short Selling Data: The short selling ratios for these companies varied, with CPIC having the highest ratio at 28.360%, while NCI had the lowest at 5.968%.
Analyst Ratings: All listed companies received an "Outperform" rating, indicating positive expectations from analysts.
Market Outlook: Citi has raised target prices for life insurers, favoring leaders like CHINA LIFE and PING AN, and anticipates a prosperous year for the Chinese life insurance sector.
Citi's Ratings and Target Prices for Chinese Insurers (Table)
Stock Performance: Various Chinese insurance companies showed mixed stock performance, with China Life and Ping An experiencing notable gains, while China Re remained stable.
Short Selling Data: Short selling activity varied across companies, with Ping An having the highest short selling amount at $345.76M and a ratio of 18.733%.
Investment Ratings: Analysts have given "Buy" ratings to China Life, CPIC, PICC Group, PICC P&C, and Ping An, while China Re, China Taiping, and NCI received "Neutral" ratings.
Target Prices: Target prices for the companies range from 1.37 to 79 HKD, indicating potential growth opportunities for investors in the insurance sector.
Citi Favors CHINA LIFE and PING AN for Chinese Insurers, and PICC P&C for Property Insurance
Citi's Report on Chinese Insurers: Citi predicts that life insurers in China will benefit from a wealth reallocation as retail investors seek higher yields from maturing bank deposits, while profit margins are expected to remain stable despite changes in product mix.
Investment Recommendations: Citi favors leading insurers like CHINA LIFE and PING AN, anticipating a significant growth divergence between these industry leaders and smaller insurers due to ongoing regulatory changes.
Property Insurance Sector Outlook: The report highlights that PICC P&C is likely to outperform in the property insurance sector, benefiting from its leading position.
Stock Ratings and Target Prices: Citi provides specific stock ratings and target prices for various insurers, recommending buys for CHINA LIFE, CPIC, and PICC P&C, while maintaining neutral ratings for others like CHINA RE and CHINA TAIPING.
JPM Favoring Asian Insurance Market (Excluding Japan/Australia) in Year of the Horse; Key Selections Include PING AN and CHINA LIFE
Price Changes in Asian Insurers: Asian insurers have seen significant price fluctuations, with Hong Kong/China insurers increasing by an average of 8%, while South Korean insurers have decreased by 2%. JPMorgan suggests that emerging markets in Asia, excluding Japan and Australia, offer better risk-reward opportunities due to stronger fundamentals.
Preference for Life Insurers: JPMorgan favors life insurers over non-life and reinsurers, citing less favorable underwriting cycles and pricing trends for the latter. Key recommendations include PING AN and CHINA LIFE among others.
Investment Ratings and Target Prices: JPMorgan has provided investment ratings and target prices for various insurers, with AIA, CHINA LIFE, and PING AN rated as "Overweight" and target prices set at 107, 40, and 100 HKD respectively.
Short Selling Data: The report includes short selling data for the mentioned stocks, indicating significant short selling activity, particularly for PING AN and CHINA LIFE, with ratios of 20.220% and 17.234% respectively.
